Baird Financial Group
INSM icon

Baird Financial Group’s Insmed INSM Stock Holding History

Baird Financial Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.89M Sell
17,688
-1,996
-10% -$307K ﹤0.01% 919
2025
Q4 		$3.43M Sell
19,684
-2,702
-12% -$493K 0.01% 863
2025
Q3 		$3.22M Sell
22,386
-3,335
-13% -$409K 0.01% 883
2025
Q2 		$2.59M Buy
+25,721
New +$1.97M ﹤0.01% 928
2025
Q1 		– Sell
-22,289
Closed -$1.54M – 1799
2024
Q4 		$1.54M Buy
+22,289
New +$1.61M ﹤0.01% 1046
2022
Q1 		– Sell
-7,651
Closed -$208K – 1872
2021
Q4 		$208K Hold
7,651
– – ﹤0.01% 1810
2021
Q3 		$211K Buy
+7,651
New +$201K ﹤0.01% 1789

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baird Financial Group's INSM Position: Q1 2026 in Review

Baird Financial Group reduced its Insmed (INSM) stake by 10% in Q1 2026, selling an estimated $307K and leaving 17,688 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Baird Financial Group first reported a position in INSM in Q3 2021 and has held it in 7 quarters since. The position peaked at $3.43M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Baird Financial Group held 17,688 shares of Insmed worth $2.89M as of Q1 2026.
  • Baird Financial Group sold 1,996 Insmed shares in Q1 2026, an estimated $307K.
  • Insmed made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #919 holding.
  • Baird Financial Group first reported a position in Insmed in Q3 2021 and has held it in 7 quarters since.
  • Baird Financial Group's Insmed position peaked at $3.43M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.